About PCYC
R & D
Therapeutic Programs
Factor VIIa Inhibitor - PCI-27483
Motexafin Gadolinium
HDAC Inhibitors
Tyrosine Kinase Inhibitors
Investors & Media
Stock Information
Events and Webcasts
SEC Filings
Corporate Governance
Press Releases
Annual Reports
Presentations
Information Request
Investor FAQs
Contact Us
Clinical Trials
CNS Cancers
Study PCYC-402
Study PCYC-403
Careers
Opportunities
Benefits
How To Apply
Board Committee Charters
Stock Information
Events and Webcasts
SEC Filings
Corporate Governance
Management
Code of Business Conduct and Ethics
Board of Directors
Board Committee Charters
The Nominating and Corporate Governance Committee
Compensation Committee Charter
Audit Committee Charter
Press Releases
Annual Reports
Presentations
Information Request
Investor FAQs
Contact Us
Audit Committee Charter
Compensation Committee Charter
Nominating and Corporate Governance Committee Charter
